PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New test for patients with sore throats cuts antibiotic use by nearly a third

2013-11-08
(Press-News.org) Contact information: Becky Attwood
r.attwood@soton.ac.uk
0238-059-5457
University of Southampton
New test for patients with sore throats cuts antibiotic use by nearly a third A new 'clinical score' test for patients with sore throats could reduce the amount of antibiotics prescribed and result in patients feeling better more quickly, research in the British Medical Journal shows.

Researchers at the University of Southampton, funded by the National Institute for Health Research (NIHR) Heath Technology Assessment (HTA) Programme, used the five-item FeverPAIN score to decide whether to prescribe patients with an antibiotic immediately or to give them a delayed prescription and compared it with simply offering a delayed prescription.

The FeverPAIN score includes; fever in the past 24 hours, a pus infection, rapid attendance (within three days), inflamed tonsils and no cough or cold symptoms.

Results showed that using the test reduced antibiotic use by almost 30 per cent and despite using fewer antibiotics, patients in the FeverPAIN score group experienced a greater improvement in symptoms.

But the use of an in-practice rapid antigen test (a test which detects the bacteria, Lancefield Group A Streptococcus, which is the most common bacterium to cause sore throats) in conjunction with the FeverPAIN score did not result in any further reductions in antibiotic use or improvements in symptoms.

Paul Little, Professor of Primary Care Research who led the research, comments: "Our findings show that using this clinical score test can target antibiotics more effectively and help persuade patients antibiotics are not needed.

"Additionally the FeverPAIN score should enable better targeting of antibiotics than the current scoring system to identify the likelihood of a bacterial infection in patients complaining of a sore throat, as it allows GPs to rule out likely streptococcal infection in more patients."

The study recruited 631 patients with an acute sore throat and compared use of the FeverPAIN clinical score, with or without rapid antigen testing, with a delayed prescription, in which patients were told to pick up a prescription three to five days later if their symptoms did not settle or got worse.

Patients who had four or five of the clinical features of the FeverPAIN test were prescribed antibiotics immediately; a delayed antibiotic prescription was offered to patients with two or three features and no antibiotics to those with only one or no features.

The test led to a 29 per cent reduction in antibiotic use compared with the delayed prescription approach. One in three patients in the FeverPAIN score group said their sore throat had improved rapidly from a moderately bad problem to a slight problem within two to four days. Moderately bad or worse symptoms also got better faster in the clinical score group.

However, the use of a rapid antigen test as well as the FeverPAIN test for patients who displayed streptococci symptoms did not offer any further improvements, with a 27 per cent reduction in antibiotic use as well as similar improvements in patients' symptoms.

Study co-author Dr Michael Moore, a GP and a reader in primary care research at the University of Southampton, adds: "Clinicians can consider using a clinical score to target antibiotic use for acute sore throat, which is likely to reduce antibiotic use and improve symptom control. There is no clear advantage in the additional use of a rapid antigen test.

"We found that the FeverPAIN score picks up bacterial throat infections more accurately than the current scoring system and importantly picks up larger numbers of patients who are at low risk of streptococcal infection giving the patient and the doctor the confidence not to use antibiotics. If you select those at the highest risk of streptococcal infection then antibiotics can be more targeted at the people who are most likely to get symptom benefit."

### END


ELSE PRESS RELEASES FROM THIS DATE:

Mother's immunosuppressive medications not likely to put fetus at risk

2013-11-08
Mother's immunosuppressive medications not likely to put fetus at risk Women with chronic autoimmune diseases who take immunosuppressive medications during their first trimester of pregnancy are not putting their babies at significantly increased ...

Study shows veterans psychologically impacted by Boston Marathon Bombing

2013-11-08
Study shows veterans psychologically impacted by Boston Marathon Bombing (Boston) - According to a new study, many Boston-area military veterans diagnosed with post-traumatic stress disorder (PTSD) experienced flashbacks, unwanted memories and other psychological ...

Safe long term storage of CO2 is possible

2013-11-08
Safe long term storage of CO2 is possible Conclusion of an international project for the geological storage of carbon dioxide Potsdam, 07.11.2013 | At the final conference of the EU project CO2CARE - CO2 Site Closure Assessment Research ...

In animal study, 'cold turkey' withdrawal from drugs triggers mental decline

2013-11-08
In animal study, 'cold turkey' withdrawal from drugs triggers mental decline SAN DIEGO – Can quitting drugs without treatment trigger a decline in mental health? That appears to be the case in an animal model of morphine addiction. Georgetown University Medical ...

NASA sees Super-Typhoon Haiyan maintain strength crossing Philippines

2013-11-08
NASA sees Super-Typhoon Haiyan maintain strength crossing Philippines Super-Typhoon Haiyan slammed into the eastern Philippines as the strongest tropical cyclone of the year, and today, Nov. 8, is exiting the country and moving into the South China Sea. NASA's Aqua ...

Drug may guard against periodontitis, and related chronic diseases

2013-11-08
Drug may guard against periodontitis, and related chronic diseases WASHINGTON, DC – November 7, 2013 – A drug currently used to treat intestinal worms could protect people from periodontitis, an advanced gum disease, which untreated can erode the structures—including ...

A new scorpion species from ancient Lycia

2013-11-08
A new scorpion species from ancient Lycia Scientists discover and describe a new species of scorpion, Euscorpius lycius, coming from the area of ancient Lycia, nowadays the regions of the Muğla and Antalya Provinces in Southwestern Turkey. With the new discovery, ...

Next-generation semiconductors synthesis

2013-11-08
Next-generation semiconductors synthesis Aluminum nitride semiconductors synthesized at significantly reduced temperatures -- Described in the journal 'Applied Physics Letters' WASHINGTON, D.C. Nov. 8, 2013 -- Although silicon semiconductors are nearly universal ...

Penn study identifies new trigger for breast cancer metastasis

2013-11-08
Penn study identifies new trigger for breast cancer metastasis For years, scientists have observed that tumor cells from certain breast cancer patients with aggressive forms of the disease contained low levels of mitochondrial DNA. But, until recently, ...

Dialysis for the elderly: New evidence from Mayo Clinic to guide shared decision-making

2013-11-08
Dialysis for the elderly: New evidence from Mayo Clinic to guide shared decision-making ROCHESTER, Minn. — New research from Mayo Clinic finds that half of elderly patients who start dialysis after age 75 will die within one year. The findings are being presented this ...

LAST 30 PRESS RELEASES:

2025 Gut Microbiota for Health World Summit to spotlight groundbreaking research

International survey finds that support for climate interventions is tied to being hopeful and worried about climate change

Cambridge scientist launches free VR platform that eliminates the fear of public speaking

Open-Source AI matches top proprietary model in solving tough medical cases

Good fences make good neighbors (with carnivores)

NRG Oncology trial supports radiotherapy alone following radical hysterectomy should remain the standard of care for early-stage, intermediate-risk cervical cancer

Introducing our new cohort of AGA Future Leaders

Sharks are dying at alarming rates, mostly due to fishing. Retention bans may help

Engineering excellence: Engineers with ONR ties elected to renowned scientific academy

New CRISPR-based diagnostic test detects pathogens in blood without amplification

Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer

Growing solar: Optimizing agrivoltaic systems for crops and clean energy

Scientists discover how to reactivate cancer’s molecular “kill switch”

YouTube influencers: gaming’s best friend or worst enemy?

uOttawa scientists use light to unlock secret of atoms

NJIT mathematician to help map Earth's last frontier with Navy grant

NASA atmospheric wave-studying mission releases data from first 3,000 orbits

‘Microlightning’ in water droplets may have sparked life on Earth

Smoke from wildland-urban interface fires more deadly than remote wildfires

What’s your body really worth? New AI model reveals your true biological age from 5 drops of blood

Protein accidentally lassos itself, helping explain unusual refolding behavior

With bird flu in raw milk, many in U.S. still do not know risks of consuming it

University of Minnesota research team awarded $3.8 million grant to develop cell therapy to combat Alzheimer’s disease

UConn uncovers new clue on what is leading to neurodegenerative diseases like Alzheimer’s and ALS

Resuscitation in out-of-hospital cardiac arrest – it’s how quickly it is done, rather than who does it

A closer look at biomolecular ‘silly putty’

Oxytocin system of breastfeeding affected in mothers with postnatal depression

Liquid metal-enabled synergetic cooling and charging: a leap forward for electric vehicles

Defensive firearm use is far less common than exposure to gun violence

Lifetime and past-year defensive gun use

[Press-News.org] New test for patients with sore throats cuts antibiotic use by nearly a third